First American Trust FSB Sells 555 Shares of Teradyne, Inc. (NASDAQ:TER)

First American Trust FSB reduced its stake in Teradyne, Inc. (NASDAQ:TERFree Report) by 0.8% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 72,460 shares of the company’s stock after selling 555 shares during the quarter. First American Trust FSB’s holdings in Teradyne were worth $9,124,000 at the end of the most recent reporting period.

Several other hedge funds have also recently bought and sold shares of TER. Vanguard Group Inc. increased its stake in shares of Teradyne by 0.5% during the fourth quarter. Vanguard Group Inc. now owns 20,405,899 shares of the company’s stock worth $2,569,511,000 after purchasing an additional 92,428 shares during the period. State Street Corp increased its position in Teradyne by 5.4% during the 3rd quarter. State Street Corp now owns 6,880,148 shares of the company’s stock worth $921,458,000 after buying an additional 350,002 shares during the period. Van ECK Associates Corp lifted its holdings in shares of Teradyne by 59.9% during the fourth quarter. Van ECK Associates Corp now owns 4,928,143 shares of the company’s stock worth $620,552,000 after buying an additional 1,846,079 shares in the last quarter. Geode Capital Management LLC boosted its position in shares of Teradyne by 5.5% in the third quarter. Geode Capital Management LLC now owns 4,011,131 shares of the company’s stock valued at $535,484,000 after acquiring an additional 209,868 shares during the period. Finally, Sumitomo Mitsui Trust Group Inc. grew its stake in shares of Teradyne by 16.2% in the fourth quarter. Sumitomo Mitsui Trust Group Inc. now owns 2,825,897 shares of the company’s stock valued at $355,837,000 after acquiring an additional 393,175 shares in the last quarter. 99.77% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

TER has been the subject of several analyst reports. KeyCorp dropped their price objective on shares of Teradyne from $150.00 to $140.00 and set an “overweight” rating for the company in a research note on Wednesday, March 12th. Robert W. Baird cut their price target on Teradyne from $140.00 to $110.00 and set an “outperform” rating for the company in a research note on Thursday, March 13th. Morgan Stanley lowered their price objective on Teradyne from $112.00 to $81.00 and set an “underweight” rating on the stock in a research note on Friday, March 14th. UBS Group set a $130.00 target price on Teradyne and gave the company a “buy” rating in a research report on Wednesday, March 12th. Finally, Susquehanna decreased their price target on Teradyne from $165.00 to $155.00 and set a “positive” rating on the stock in a research report on Wednesday, March 12th. Two equities research analysts have rated the stock with a sell rating, three have assigned a hold rating, twelve have assigned a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, Teradyne currently has an average rating of “Moderate Buy” and an average price target of $121.44.

Check Out Our Latest Report on Teradyne

Insider Activity at Teradyne

In other news, CFO Sanjay Mehta sold 1,384 shares of the firm’s stock in a transaction dated Tuesday, February 4th. The stock was sold at an average price of $111.49, for a total transaction of $154,302.16. Following the completion of the transaction, the chief financial officer now directly owns 36,576 shares in the company, valued at $4,077,858.24. This trade represents a 3.65 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Gregory Stephen Smith sold 3,080 shares of the company’s stock in a transaction that occurred on Friday, January 3rd. The shares were sold at an average price of $130.00, for a total value of $400,400.00. Following the completion of the sale, the chief executive officer now owns 74,660 shares in the company, valued at $9,705,800. The trade was a 3.96 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 8,479 shares of company stock worth $1,013,134 in the last quarter. 0.36% of the stock is owned by insiders.

Teradyne Price Performance

Shares of NASDAQ:TER opened at $91.00 on Tuesday. The firm has a 50 day simple moving average of $111.88 and a 200 day simple moving average of $118.43. The company has a market cap of $14.72 billion, a price-to-earnings ratio of 27.33, a PEG ratio of 2.83 and a beta of 1.46. Teradyne, Inc. has a one year low of $82.98 and a one year high of $163.21.

Teradyne (NASDAQ:TERGet Free Report) last released its quarterly earnings data on Wednesday, January 29th. The company reported $0.95 earnings per share for the quarter, beating the consensus estimate of $0.91 by $0.04. Teradyne had a return on equity of 19.08% and a net margin of 19.23%. As a group, analysts expect that Teradyne, Inc. will post 3.88 EPS for the current year.

Teradyne Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, March 14th. Stockholders of record on Friday, February 14th were paid a $0.12 dividend. This represents a $0.48 annualized dividend and a dividend yield of 0.53%. The ex-dividend date was Friday, February 14th. Teradyne’s dividend payout ratio is currently 14.41%.

Teradyne Company Profile

(Free Report)

Teradyne, Inc designs, develops, manufactures, and sells automated test systems and robotics products worldwide. It operates through four segments; Semiconductor Test, System Test, Robotics, and Wireless Test. The Semiconductor Test segment offers products and services for wafer level and device package testing of semiconductor devices in automotive, industrial, communications, consumer, smartphones, cloud, computer and electronic game, and other applications.

See Also

Institutional Ownership by Quarter for Teradyne (NASDAQ:TER)

Receive News & Ratings for Teradyne Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teradyne and related companies with MarketBeat.com's FREE daily email newsletter.